Pay in 4 interest-free payments of $5.76 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
GLP-1 therapies just got a whole lot less expensive for patients who pay out of pocket
Chin Med J 129(20):24272433
Recent data suggest potential benefits in heart failure with preserved ejection fraction (HFpEF) with obesity, but monitoring is important, particularly during initiation
Importantly, localized increases in GLP-1, such as that occur in the gut and portal vein, often have a more profound effect than systemic elevations, emphasizing the therapeutic potential of targeting regional activity rather than relying solely on systemic concentrations
Available from: Zapadka KL, Becher FJ, Gomes Dos Santos AL, Jackson SE
US$ 25.20
US$ 29.45
US$ 25.05
US$ 21.44
